Clinical Radiology
Volume 64, Issue 11 , Pages 1067-1074 , November 2009

Diffusion-weighted imaging in predicting and monitoring the response of uterine cervical cancer to combined chemoradiation

  • Y. Liu

      Affiliations

    • Department of Radiology, General Hospital of Tianjin Medical University, Tianjin, China
    • ,
  • R. Bai

      Affiliations

    • Department of Radiology, General Hospital of Tianjin Medical University, Tianjin, China
    • Corresponding Author InformationGuarantor and correspondent: Renju Bai, Department of Radiology, General Hospital of Tianjin Medical University, Tianjin, China. Tel.: +86 022 60362911; fax: +86 022 60362990.
    • ,
  • H. Sun

      Affiliations

    • Department of Radiology, General Hospital of Tianjin Medical University, Tianjin, China
    • ,
  • H. Liu

      Affiliations

    • Department of Radiology, Tianjin Central Hospital of Gynecology and Obstetrics, Tianjin, China
    • ,
  • X. Zhao

      Affiliations

    • Department of Radiology, General Hospital of Tianjin Medical University, Tianjin, China
    • ,
  • Y. Li

      Affiliations

    • Department of Radiology, General Hospital of Tianjin Medical University, Tianjin, China

Received 27 November 2008 ,Revised 23 June 2009 ,Accepted 7 July 2009.

References 

  1. Jeong YY, Kang HK, Chung TW, et al. Uterine cervical carcinoma after therapy: CT and MR imaging findings. RadioGraphics. 2003;23:969
  2. Sahdev A, Sohaib SA, Wenaden AE, et al. The performance of magnetic resonance imaging in early cervical carcinoma: a long-term experience. Int J Gynecol Cancer. 2007;17:629
  3. Engin G. Cervical cancer: MR imaging findings before, during, and after radiation therapy. Eur Radiol. 2006;16:313
  4. Kaur H, Silverman PM, Iyer RB, et al. Diagnosis, staging, and surveillance of cervical carcinoma. AJR Am J Roentgenol. 2003;180:1621
  5. Flueckiger F, Ebner F, Poschauko H, et al. Cervical cancer: serial MR imaging before and after primary radiation therapy—a 2-year follow-up study. Radiology. 1992;184:89
  6. Hricak H, Swift PS, Campos Z, et al. Irradiation of the cervix uteri: value of unenhanced and contrast-enhanced MR imaging. Radiology. 1993;189:381
  7. Kinkel K, Ariche M, Tardivon AA, et al. Differentiation between recurrent tumor and benign conditions after treatment of gynecologic pelvic carcinoma: value of dynamic contrast-enhanced subtraction MR imaging. Radiology. 1997;204:55
  8. Koh DM, Scurr E, Collins D, et al. Predicting response of colorectal hepatic metastasis: value of pretreatment apparent diffusion coefficients. AJR Am J Roentgenol. 2007;188:1001
  9. Ross BD, Moffat BA, Lawrence TS, et al. Evaluation of cancer therapy using diffusion magnetic resonance imaging. Mol Cancer Ther. 2003;2:581
  10. Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst. 2000;92:205
  11. Ohara K, Tanaka Y, Tsunoda H, et al. Assessment of cervical cancer radioresponse by serum squamous cell carcinoma antigen and magnetic resonance imaging. Obstet Gynecol. 2002;100:781
  12. Thoeny HC, De Keyzer F, Chen F, et al. Diffusion-weighted MR imaging in monitoring the effect of a vascular targeting agent on rhabdomyosarcoma in rats. Radiology. 2005;234:756
  13. Chenevert TL, Stegman LD, Taylor JM, et al. Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors. J Natl Cancer Inst. 2000;92:2029
  14. Jennings D, Hatton BN, Guo J, et al. Early response of prostate carcinoma xenografts to docetaxel chemotherapy monitored with diffusion MRI. Neoplasia. 2002;4:255
  15. Mardor Y, Roth Y, Lidar Z, et al. Monitoring response to convection-enhanced taxol delivery in brain tumor patients using diffusion-weighted magnetic resonance imaging. Cancer Res. 2001;61:4971
  16. Dzik-Jurasz A, Domenig C, George M, et al. Diffusion MRI for prediction of response of rectal cancer to chemoradiation. Lancet. 2002;360:307
  17. Hein PA, Kremser C, Judmaier W, et al. Diffusion-weighted MRI–a new parameter for advanced rectal carcinoma?. Rofo. 2003;175:381;[in German]
  18. Chen CY, Li CW, Kuo YT, et al. Early response of hepatocellular carcinoma to transcatheter arterial chemoembolization: choline levels and MR diffusion constants—initial experience. Radiology. 2006;239:448
  19. Koh DM, Collins DJ. Diffusion-weighted MRI in the body: applications and challenges in oncology. AJR Am J Roentgenol. 2007;188:1622
  20. Roth Y, Tichler T, Kostenich G, et al. High-b-value diffusion-weighted MR imaging for pretreatment prediction and early monitoring of tumor response to therapy in mice. Radiology. 2004;232:685
  21. Moffat BA, Chenevert TL, Lawrence TS, et al. Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response. Proc Natl Acad Sci USA. 2005;102:5524
  22. Moffat BA, Hall DE, Stojanovska J, et al. Diffusion imaging for evaluation of tumor therapies in preclinical animal models. MAGMA. 2004;17:249

PII: S0009-9260(09)00256-6

doi: 10.1016/j.crad.2009.07.010

Clinical Radiology
Volume 64, Issue 11 , Pages 1067-1074 , November 2009

Article Tools

* Image Usage & Resolution